Skip to content

Investor Relations / Publications / Publications Search

Publications Search

Budoff MJ, Muhlestein JB, Bhatt DL, et al. Effect of Icosapent Ethyl on Progression of Coronary Atherosclerosis in Patients with Elevated Triglycerides on Statin Therapy: A prospective, placebo-controlled randomized trial (EVAPORATE): Interim Results [published online ahead of print, 2020 Jul 1]. Cardiovasc Res. 2020;cvaa184. doi:10.1093/cvr/cvaa184

https://academic.oup.com/cardiovascres/article-abstract/doi/10.1093/cvr/cvaa184/5865857

Lakshmanan S, Shekar C, Dahal S, Onuegbu A, Kinninger A, Cai A, Birudaraju D, Cherukuri L, Golub I, Rezvanizadeh V, Dailing C, Flores F, Hamal S, Roy SK, Nelson J, Budoff MJ. Association of HDL subclasses with baseline coronary plaque burden by coronary computed tomography angiography (CCTA) from EVAPORATE (effect of Vascepa on improving coronary atherosclerosis in people with high triglycerides taking statin therapy) trial [abstract]. J Am Coll Cardiol 2020;75(11 suppl 1):1624

http://www.onlinejacc.org/content/75/11_Supplement_1/1624

Lakshmanan S, Shekar C, Dahal S, Onuegbu A, Kinninger A, Cai A, Rezvanizadeh V, Golub I, Birudaraju D, Cherukuri L, Hamal S, Dailing C, Flores F, Roy SK, Nelson J, Budoff MJ. Association of inflammatory markers with baseline coronary plaque volumes by coronary computed tomography angiography (CCTA) from EVAPORATE (effect of Vascepa on improving coronary atherosclerosis in people with high triglycerides taking statin therapy) trial [abstract]. J Am Coll Cardiol 2020;75(11 suppl 10:1720. 

http://www.onlinejacc.org/content/75/11_Supplement_1/1720

Lakshmanan S, Shekar C, Kinninger A, Dahal S, Onuegbu A, Cai AN, Hamal S, Birudaraju D, Roy SK, Nelson JR, Budoff MJ, Bhatt DL. Comparison of mineral oil and non-mineral oil placebo on coronary plaque progression by coronary computed tomography angiography. Cardiovasc Res. 2020;116(3):479-82.

https://doi.org/10.1093/cvr/cvz329

Budoff MJ, Bhatt DL, Kinninger A, et al. Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial. Eur Heart J. 2020; epub ahead of print.

https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehaa652/5898836

American Heart Association
Budoff MJ, Muhlestein JB, Bhatt DL, Le VT, May HT, Shaikh K, Shekar C, Kinninger A, Lakshmanan S, Roy S, Tayek J, Nelson JR. Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides (200-499 mg/dL) on statin therapy (EVAPORATE study) [abstract]. Presented at: Annual Scientific Sessions of the American Heart Association; November 16-18, 2019, 2019; Philadelphia, PA.

https://www.abstractsonline.com/pp8/#!/7891/presentation/35090

Budoff M, Brent Muhlestein J, Le VT, May HT, Roy S, Nelson JR. Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200–499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study. Clin Cardiol. 2018;1–7.
Free:

https://doi.org/10.1002/clc.22856

Budoff M, Muhlestein JB, Le VT, May HT, Roy S, Nelson JR. Effect of Vascepa (icosapent ethyl) on progression of coronary atherosclerosis in patients with elevated triglycerides (200–499 mg/dL) on statin therapy: Rationale and design of the EVAPORATE study. Clin Cardiol. 2018;41:13-19.
Free:
http://onlinelibrary.wiley.com/doi/10.1002/clc.22856/full

http://onlinelibrary.wiley.com/doi/10.1002/clc.22856/full

National Lipid Association
Lee A, Kinninger A, Jayawardena E, Shekar C, Cherukuri L, Dailing C, Hamal S, Flores F, Budoff M, Nelson J. Relationship between lipid levels and coronary atherosclerotic plaque scores by coronary computed tomography angiography (CTA) in subjects with elevated triglyceridesJ Clin Lipidol. 2019.

https://www.lipidjournal.com/article/S1933-2874(19)30125-4/fulltext

Cherukuri L, Shekar C, Kinninger A, Birudaraju D, Hamal S, Flores F, Tayek J, Roy S, Budoff M, Nelson J, Johanis A. Comparison of atherosclerotic plaque characteristics among normal and high triglycerides (TGs) patientsJ Clin Lipidol. 2019; epub ahead of print.
https://www.lipidjournal.com/article/S1933-2874(19)30118-7/fulltext

https://www.lipidjournal.com/article/S1933-2874(19)30118-7/fulltext
copyright
© 2021, Amarin Corporation
Privacy policy  |  Disclaimer
Dublin Office
Spaces South Docklands
Block C
77 Sir John Rogerson's Quay
Dublin 2, D02 VK60
Investor Relations
AMARIN CORPORATION PLC C/O AMARIN PHARMA, INC.
440 ROUTE 22
BRIDGEWATER, NJ 08807
investor.relations@amarincorp.com
Fax:
+1 908 719 3012

Amarin Corporation